# Malaria Vaccine Development Requirements
# Based on Plasmodium falciparum circumsporozoite protein (CSP)

## Target Specifications
PRIMARY_ANTIGEN=NANPNANPNANP
ANTIGEN_TYPE=CSP_REPEAT_EPITOPE
PATHOGEN=Plasmodium_falciparum
VACCINE_TYPE=mRNA_subunit

## Technical Requirements
EXPRESSION_SYSTEM=mammalian
CODON_OPTIMIZATION=human
SIGNAL_PEPTIDE=tPA
ADJUVANT_COMPATIBILITY=required

## Regulatory Standards
SAFETY_LEVEL=clinical_grade
GMP_COMPATIBLE=true
IMMUNOGENICITY_PROFILE=cellular_and_humoral

## Quality Metrics
MIN_EXPRESSION_LEVEL=moderate
MAX_GC_CONTENT=70
MIN_GC_CONTENT=30
CODON_ADAPTATION_INDEX=optimized

## Validation Requirements
IN_SILICO_VALIDATION=required
SEQUENCE_INTEGRITY=required
ORF_FRAME_CHECK=required
COMPONENT_VALIDATION=required

## Documentation Requirements
DESIGN_RATIONALE=required
QUALITY_METRICS=required
VALIDATION_RESULTS=required
MANUFACTURING_NOTES=required
